Science and Medicine
Technology Platforms
Products Center
About Us
Full Value Chain
News
Investor Relations
Corporate Governance
Announcements and Circulars
Presentations
Financial Report
Investor Inquiry
Contact Us
SC
TC
EN
SC
TC
EN
Science and Medicine
Technology Platforms
Products Center
About Us
Full Value Chain
News
Investor Relations
Corporate Governance
Announcements and Circulars
Presentations
Financial Report
Investor Inquiry
Contact Us
EDDING Group and Genor Bio have completed the merger
News List
Previous
EDG Announced EDP167 has successfully completed the first subject dosing in its Phase II clinical trial
Back to List
EDDING Announces NMPA Approval Of VASCEPA® (Icosapent Ethyl) For New Cardiovascular Risk Reduction (CVRR) Indication in Mainland China
Next
